Over 408 Million COVID-19 Tests Completed

The U.S. CDC Data Tracker reported on April 28, 2021, over 408 million RT-PCR diagnostic tests have been performed to confirm SARS-CoV-2 virus infections during the COVID-19 pandemic.

Recent data compiled by Statista on April 20, 2021, indicates the USA leads all other counties in COVID-19 tests processed, followed by India (270m) and China (160m).

Previously, the U.S. Food and Drug Administration (FDA) announced on April 27, 2021, it had authorized 369 coronavirus diagnostic tests, including 270 molecular tests, 76 antibody tests, and 23 antigen tests during the COVID-19 pandemic.

Furthermore, 49 molecular authorizations can be used with home-collected samples. There is one molecular prescription at-home test, two antigen prescription at-home tests, four OTC at-home antigen tests, and two OTC molecular tests.

The FDA recently published A Closer Look at COVID-19 Diagnostic Testing to offer those who might purchase COVID-19 tests more technical information and resources.